Shares of Clinuvel Pharmaceuticals Limited (OTCMKTS:CLVLY – Get Free Report) traded down 3.1% during mid-day trading on Thursday . The company traded as low as $9.45 and last traded at $9.45. 1,148 shares were traded during mid-day trading, a decline of 58% from the average session volume of 2,762 shares. The stock had previously closed at $9.75.
Clinuvel Pharmaceuticals Price Performance
The stock has a 50 day moving average of $9.65 and a 200-day moving average of $9.85.
Clinuvel Pharmaceuticals Increases Dividend
The company also recently announced a dividend, which was paid on Monday, September 30th. Investors of record on Monday, September 9th were paid a $0.0299 dividend. This is a positive change from Clinuvel Pharmaceuticals’s previous dividend of $0.03. The ex-dividend date of this dividend was Monday, September 9th.
Clinuvel Pharmaceuticals Company Profile
Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP).
Featured Articles
- Five stocks we like better than Clinuvel Pharmaceuticals
- What is a Bond Market Holiday? How to Invest and Trade
- Misses and Beats: 3 Stocks That Are Moving Markets Right Now
- Investing In Automotive Stocks
- Cisco on the Rise: AI Potential and Analyst Upgrades Drive Gains
- How to Invest in the FAANG Stocks
- MarketBeat Week in Review – 10/14 – 10/18
Receive News & Ratings for Clinuvel Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clinuvel Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
